Skip to main content

Table 4 Daily life activities questionnaires and functional goals

From: Efficacy of integrating a semi-immersive virtual device in the HABIT-ILE intervention for children with unilateral cerebral palsy: a non-inferiority randomized controlled trial

  

Mean ± SD

Mean changes ± SD

One way RMANOVAa

MCID

Non inferiority tests

         

p-value; 90% CIb

  

T1

T2

T3

T2–T1

T3–T1

p-value

 

T2–T1

T3–T1

ABILHAND-Kids

REAtouch®

1.6 ± 1.8

2.5 ± 2.3

2.4 ± 1.9

0.8 ± 0.9

0.9 ± 0.9

 < 0.001*

0.718

0.18

0.050*

 Logits

HABIT-ILE

1.2 ± 1.4

2.4 ± 1.6

2.18 ± 2

1.25 ± 1.2

0.9 ± 1.4

 < 0.001*

[− 1; 0.2]

[− 0.7; 0.67]

ACTIVLIM-CP

REAtouch®

1.9 ± 1.3

2.8 ± 1.8

2.4 ± 1.4

0.97 ± 0.8

0.75 ± 0.5

 < 0.001*

0.482

0.016*

0.008*

 Logits

HABIT-ILE

1.8 ± 1.1

2.5 ± 1.2

2.4 ± 1.2

0.76 ± 1

0.67 ± 0.7

0.002*

[− 0.3; 0.7]

[− 0.3; 0.4]

ABILOCO-Kids

REAtouch®

2.7 ± 1.7

3.2 ± 1.7

3.3 ± 1.8

0.5 ± 1.3

0.7 ± 1.1

0.063

0.753

0.21

0.026*

 Logits

HABIT-ILE

3.2 ± 1.8

4.1 ± 2.1

3.8 ± 2.1

0.9 ± 1.5

0.5 ± 1.5

0.029*

[− 1.1; 0.4]

[− 0.6; 0.9]

PEDI

REAtouch®

46.5 ± 10

53.7 ± 8

54.1 ± 6

7.2 ± 5

8.3 ± 5

 < 0.001*,a

3.17

0.06

0.047*

 Raw score (/63)

HABIT-ILE

47.3 ± 10

54 ± 8

54.1 ± 8

6.6 ± 8

7.6 ± 7

0.004*,a

[− 3.4; 4.4]

[− 3; 4.4]

COPM-P

REAtouch®

3.1 ± 1.3

7.6 ± 1

7.1 ± 1

4.4 ± 1.3

4 ± 1.3

 < 0.001*,a

2

0.001*

0.001*

 Raw score (/10)

HABIT-ILE

2.7 ± 0.9

7.7 ± 1

7.2 ± 0.9

4.9 ± 1.3

4.4 ± 1.3

 < 0.001*,a

[− 1.2; 0.1]

[− 1.2; 0.3]

COPM-S

REAtouch®

3 ± 1.2

8.3 ± 1.3

7.6 ± 1.2

5.2 ± 1.4

4.5 ± 1.3

 < 0.001*,a

2

 < 0.001*

 < 0.001*

 Raw score (/10)

HABIT-ILE

2.9 ± 1.2

8 ± 0.9

7.6 ± 0.9

5.1 ± 1.4

4.5 ± 1.7

 < 0.001*,a

[1; …[b

[− 1; …[b

  1. Outcome results on every testing sessions and values reported for statistical analyses. Mean values at every testing session are calculated with all the available data, no intent to treat. Mean changes are reported based on data used for non-inferiority analyses, no intent to treat and uncompleted data not included
  2. SD standard deviation, MCID minimal clinical important difference, CI confidence interval, PEDI Pediatric Evaluation of Disability Inventory, COPM Canadian Occupation Performance measure, perf performance measure, sat satisfaction measure
  3. aFriedmann RMANOVA on ranks
  4. b95% CI was calculated for non-parametric Mann-Withney analyses
  5. *Significant results (p < 0.05)